Comparing These Four Peptides | Compound | Primary Target | Main Effect | |---|---|---| | Sermorelin | GHRH Receptor | Stimulates endogenous GH release | | CJC-1295 | GHRH Receptor | Sustained GH stimulation | | Ipamorelin | Ghrelin Receptor (GHS-R1a) | Triggers GH secretion | | IGF-1 LR3 | IGF-1 Receptor | Direct tissue-level IGF signaling | For a deeper dive into the specific compounds available, see our Peptide Therapy Education page, which catalogs 23 active peptide compounds with full mechanism-of-action references
Pooled analysis and meta-analysis of glutathione S -transferase M1 and bladder cancer: a HuGE review
The potential role of prostaglandins (PG), including that of PGE 1 and PGE 2 , are directly associated with inflammation and could affect the function of immune cells
Reduced p27Kip-1 levels, often due to overexpression of the F-box protein Skp2, are associated with tumor progression and poor prognosis in various cancers
Compare Dihexa by mechanism, evidence strength, expected timeline, side-effect profile, and whether its primary use case matches your goal